Migrants' living conditions, perceived health needs and implications for the use of antibiotics and antimicrobial resistance in the United Kingdom: A qualitative study.
antibiotics
antimicrobial resistance
living conditions
migrants
sanitation and hygiene (WASH)
water
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
12
06
2023
revised:
05
10
2023
accepted:
11
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) is among the top public health concerns around the globe. Migrants, especially forced migrants, could be at higher risk of acquiring and transmitting AMR during their journeys or in host countries. There is limited understanding regarding migrants' living conditions and the wider factors contributing to their risk of acquiring infections, and behaviors around antimicrobial use, and AMR development. In this study, we aimed to explore transit experiences, living conditions, and antibiotic use of migrants living in the United Kingdom. We conducted semistructured qualitative interviews with 27 participants and identified five themes regarding migrants' journey and their living conditions during transit and after arriving in the United Kingdom, their access to water, sanitation and hygiene (WASH), and their use of antibiotics. Migrants, particularly forced migrants, experienced unfavorable living conditions, poor access to WASH, and challenges in accessing healthcare, which further contributed to health conditions like urinary and skin problems. Isolation and difficulty in accessing healthcare played significant roles in migrants' perceived need for storing and using antibiotics as a safety net. The findings highlight the need for coordinated and multilevel interventions to address these challenges and contribute toward tackling AMR and improving the health of this population group.
Sections du résumé
Background and Aims
UNASSIGNED
Antimicrobial resistance (AMR) is among the top public health concerns around the globe. Migrants, especially forced migrants, could be at higher risk of acquiring and transmitting AMR during their journeys or in host countries. There is limited understanding regarding migrants' living conditions and the wider factors contributing to their risk of acquiring infections, and behaviors around antimicrobial use, and AMR development. In this study, we aimed to explore transit experiences, living conditions, and antibiotic use of migrants living in the United Kingdom.
Methods
UNASSIGNED
We conducted semistructured qualitative interviews with 27 participants and identified five themes regarding migrants' journey and their living conditions during transit and after arriving in the United Kingdom, their access to water, sanitation and hygiene (WASH), and their use of antibiotics.
Results
UNASSIGNED
Migrants, particularly forced migrants, experienced unfavorable living conditions, poor access to WASH, and challenges in accessing healthcare, which further contributed to health conditions like urinary and skin problems. Isolation and difficulty in accessing healthcare played significant roles in migrants' perceived need for storing and using antibiotics as a safety net.
Conclusion
UNASSIGNED
The findings highlight the need for coordinated and multilevel interventions to address these challenges and contribute toward tackling AMR and improving the health of this population group.
Identifiants
pubmed: 37885468
doi: 10.1002/hsr2.1655
pii: HSR21655
pmc: PMC10599099
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1655Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
L. B. N. is supported by an Academy of Medical Sciences Springboard Award (SBF005/1047). M. P. reports grants from Sanofi and Gilead outside the current work and has received consulting fees from QIAGEN and Pfizer. The remaining authors declare no conflict of interest.
Références
Front Public Health. 2020 Nov 04;8:535668
pubmed: 33251170
Infect Drug Resist. 2022 Jan 13;15:127-133
pubmed: 35046676
J Glob Infect Dis. 2019 Jan-Mar;11(1):36-42
pubmed: 30814834
Patient Educ Couns. 2008 Oct;73(1):146-52
pubmed: 18640805
Neurol Res Pract. 2020 May 27;2:14
pubmed: 33324920
BMC Prim Care. 2022 May 2;23(1):100
pubmed: 35501699
Soc Sci Med. 2018 Sep;213:199-219
pubmed: 30142501
Travel Med Infect Dis. 2021 May-Jun;41:102045
pubmed: 33798743
BMC Health Serv Res. 2017 Dec 8;17(1):814
pubmed: 29216876
Br J Gen Pract. 2016 Nov;66(652):e802-e809
pubmed: 27578814
J Water Health. 2009 Dec;7(4):557-68
pubmed: 19590123
Health Sci Rep. 2023 Oct 25;6(10):e1655
pubmed: 37885468
Int J Equity Health. 2022 Feb 19;21(1):27
pubmed: 35183166
Eur J Public Health. 2018 Oct 1;28(5):910-916
pubmed: 30010744
Ethn Health. 2004 Feb;9(1):55-73
pubmed: 15203465
BMJ Open. 2022 Jan 11;12(1):e053661
pubmed: 35017249
J Antimicrob Chemother. 2012 Sep;67(9):2090-100
pubmed: 22678728
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1074-1083
pubmed: 33886141
Lancet Infect Dis. 2018 Jul;18(7):796-811
pubmed: 29779917
Br J Gen Pract. 2019 Aug;69(685):e537-e545
pubmed: 30745354